Is Diamondback Energy a Good Stock to Buy?
Diamondback Energy (FANG) is a lesser-known diamond in the rough…
Sell
24
TRDA Quote, Financials, Valuation and Earnings
Last price:
$9.87
Seasonality move
:
1.7%
Day range:
$10.08 - $10.87
52-week range:
$10.08 - $21.79
Dividend yield:
0%
P/E ratio:
5.33x
P/S ratio:
1.86x
P/B ratio:
0.89x
Volume:
66.9K
Avg. volume:
118.3K
1-year change:
-23.95%
Market cap:
$382.5M
Revenue:
$210.8M
EPS (TTM):
$1.91
TRDA Analysts' Consensus Rating
The 4 analysts providing 12-month price projections for Entrada Therapeutics shares anticipate an average target of $25.43, ranging from a low estimate of $20.00 to a high estimate of $30.00. This average target implies a growth of 149.9% compared to the current stock price of $10.18.
Consensus Price Target
$25.43
Highest Price Target
$30.00
Lowest Price Target
$20.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 0 | 4 | 4 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Consensus | -- | Buy | Buy |
TRDA Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Is Hindsight Bias In Investing?
You’ve probably heard the expression “hindsight is 20/20.” That saying…
Is Rivian a Good Stock a Buy?
Rivian Automotive (RIVN) had an initial IPO of close to…
Stock Ideas
Buy
58
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Sell
29
UNF alert for Mar 26
UniFirst [UNF] is up 0.24% over the past day.
Sell
30
KEQU alert for Mar 26
Kewaunee Scientific [KEQU] is down 1.45% over the past day.
Buy
82
EPAC alert for Mar 26
Enerpac Tool Group [EPAC] is down 3.19% over the past day.
